9
Views
0
CrossRef citations to date
0
Altmetric
Review

Update on filaggrin mutations and atopic dermatitis

, &
Pages 315-323 | Published online: 10 Jan 2014

References

  • Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J. Invest. Dermatol.84(3), 191–194 (1985).
  • McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol. Med.14(1), 20–27 (2008).
  • McGrath JA. Filaggrin and the great epidermal barrier grief. Australas. J. Dermatol.49(2), 67–73; quiz 73–64 (2008).
  • Smith FJ, Irvine AD, Terron-Kwiatkowski A et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat. Genet.38(3), 337–342 (2006).
  • Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics. Br. J. Dermatol.162(3), 472–477 (2010).
  • Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J. Invest. Dermatol.126(6), 1200–1202 (2006).
  • Van Den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ339, b2433 (2009).
  • Akiyama M, Shimizu H. An update on molecular aspects of the non-syndromic ichthyoses. Exp. Dermatol.17(5), 373–382 (2008).
  • Steinert PM, Cantieri JS, Teller DC, Lonsdale-Eccles JD, Dale BA. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc. Natl Acad. Sci. USA78(7), 4097–4101 (1981).
  • Dale BA, Resing KA, Lonsdale-Eccles JD. Filaggrin: a keratin filament associated protein. Ann. NY Acad. Sci.455, 330–342 (1985).
  • Listwan P, Rothnagel JA. Keratin bundling proteins. Methods Cell. Biol.78, 817–827 (2004).
  • Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: Role in skin barrier function and disease. J. Cell Sci.122(Pt 9), 1285–1294 (2009).
  • Sandilands A, Terron-Kwiatkowski A, Hull PR et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat. Genet.39(5), 650–654 (2007).
  • Gan SQ, Mcbride OW, Idler WW, Markova N, Steinert PM. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry29(40), 9432–9440 (1990).
  • Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol. Ther.17(Suppl. 1), 43–48 (2004).
  • Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J. Cell Biol.180(3), 451–458 (2008).
  • Denecker G, Hoste E, Gilbert B et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat. Cell Biol.9(6), 666–674 (2007).
  • Fleckman P, Brumbaugh S. Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris. Exp. Dermatol.11(4), 327–336 (2002).
  • South AP, Cabral A, Ives JH et al. Human epidermal differentiation complex in a single 2.5 mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps. J. Invest. Dermatol.112(6), 910–918 (1999).
  • Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat. Rev. Immunol.4(12), 978–988 (2004).
  • O’Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J. Allergy Clin. Immunol.124(3 Suppl. 2), R2–R6 (2009).
  • Ginger RS, Blachford S, Rowland J, Rowson M, Harding CR. Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch. Dermatol. Res.297(6), 235–241 (2005).
  • Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H. Flg mutation p.Lys4021x in the c-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. Br. J. Dermatol.161(6), 1387–1390 (2009).
  • Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet.38(4), 441–446 (2006).
  • Sandilands A, O’Regan GM, Liao H et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J. Invest. Dermatol.126(8), 1770–1775 (2006).
  • Nomura T, Sandilands A, Akiyama M et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J. Allergy Clin. Immunol.119(2), 434–440 (2007).
  • Nomura T, Akiyama M, Sandilands A et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J. Invest. Dermatol.128(6), 1436–1441 (2008).
  • Hsu CK, Akiyama M, Nemoto-Hasebe I et al. Analysis of Taiwanese ichthyosis vulgaris families further demonstrates differences in FLG mutations between European and Asian populations. Br. J. Dermatol.161(2), 448–451 (2009).
  • Nemoto-Hasebe I, Akiyama M, Nomura T, Sandilands A, McLean WH, Shimizu H. FLG mutation p.Lys4021x in the c-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. Br. J. Dermatol.161(6), 1387–1390 (2009).
  • Nomura T, Akiyama M, Sandilands A et al. Prevalent and rare mutations in the gene encoding filaggrin in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J. Invest. Dermatol.129(5), 1302–1305 (2009).
  • Hamada T, Sandilands A, Fukuda S et al.De novo occurrence of the filaggrin mutation p.R501x with prevalent mutation c.3321dela in a Japanese family with ichthyosis vulgaris complicated by atopic dermatitis. J. Invest. Dermatol.128(5), 1323–1325 (2008).
  • Chen H, Ho JC, Sandilands A et al. Unique and recurrent mutations in the filaggrin gene in Singaporean Chinese patients with ichthyosis vulgaris. J. Invest. Dermatol.128(7), 1669–1675 (2008).
  • Kang TW, Lee JS, Oh SW, Kim SC. Filaggrin mutation c.3321dela in a Korean patient with ichthyosis vulgaris and atopic dermatitis. Dermatology218(2), 186–187 (2009).
  • Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin. Exp. Allergy34(4), 520–526 (2004).
  • Bieber T. Atopic dermatitis. N. Engl. J. Med.358(14), 1483–1494 (2008).
  • Mancini AJ, Kaulback K, Chamlin Sl. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr. Dermatol.25(1), 1–6 (2008).
  • Leung Dy, Bieber T. Atopic dermatitis. Lancet361(9352), 151–160 (2003).
  • Aalto-Korte K. Improvement of skin barrier function during treatment of atopic dermatitis. J. Am. Acad. Dermatol.33(6), 969–972 (1995).
  • Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol.47(2), 198–208 (2002).
  • Hata M, Tokura Y, Takigawa M et al. Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis. Lab. Invest.82(11), 1451–1461 (2002).
  • Baurecht H, Irvine AD, Novak N et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J. Allergy Clin. Immunol.120(6), 1406–1412 (2007).
  • Wells RS, Kerr CB. Genetic classification of ichthyosis. Arch. Dermatol.92(1), 1–6 (1965).
  • Kuokkanen K. Ichthyosis vulgaris. A clinical and histopathological study of patients and their close relatives in the autosomal dominant and sex-linked forms of the disease. Acta Derm. Venereol. Suppl. (Stockh.)62, 1–72 (1969).
  • Tay YK, Khoo BP, Goh CL. The epidemiology of atopic dermatitis at a tertiary referral skin center in Singapore. Asian Pac. J. Allergy Immuno.l17(3), 137–141 (1999).
  • Compton JG, Digiovanna JJ, Johnston KA, Fleckman P, Bale SJ. Mapping of the associated phenotype of an absent granular layer in ichthyosis vulgaris to the epidermal differentiation complex on chromosome 1. Exp. Dermatol.11(6), 518–526 (2002).
  • Sugiura H, Ebise H, Tazawa T et al. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br. J. Dermatol.152(1), 146–149 (2005).
  • Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T. Decreased expression of filaggrin in atopic skin. Arch. Dermatol. Res.288(8), 442–446 (1996).
  • Elias PM, Feingold KR. Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch. Dermatol.137(8), 1079–1081 (2001).
  • Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML. The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch. Dermatol.139(11), 1417–1422 (2003).
  • Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J. Invest. Dermatol.127(7), 1667–1672 (2007).
  • Marenholz I, Nickel R, Ruschendorf F et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J. Allergy Clin. Immunol.118(4), 866–871 (2006).
  • Ruether A, Stoll M, Schwarz T, Schreiber S, Folster-Holst R. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br. J. Dermatol.155(5), 1093–1094 (2006).
  • Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J. Allergy Clin. Immunol.118(1), 214–219 (2006).
  • Barker JN, Palmer CN, Zhao Y et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J. Invest. Dermatol.127(3), 564–567 (2007).
  • Stemmler S, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S. Two common loss-of-function mutations within the filaggrin gene predispose for early onset of atopic dermatitis. J. Invest. Dermatol.127(3), 722–724 (2007).
  • Weidinger S, Rodriguez E, Stahl C et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J. Invest. Dermato.l127(3), 724–726 (2007).
  • Ching GK, Hon KL, Ng PC, Leung TF. Filaggrin null mutations in childhood atopic dermatitis among the Chinese. Int. J. Immunogenet.36(4), 251–254 (2009).
  • Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J. Invest. Dermatol.115(6), 1072–1081 (2000).
  • Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse flg gene facilitates enhanced percutaneous allergen priming. Nat. Genet.41(5), 602–608 (2009).
  • Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol.112(6 Suppl.), S118–S127 (2003).
  • De Benedetto A, Qualia CM, Baroody FM, Beck LA. Filaggrin expression in oral, nasal, and esophageal mucosa. J. Invest. Dermatol.128(6), 1594–1597 (2008).
  • Ying S, Meng Q, Corrigan CJ, Lee TH. Lack of filaggrin expression in the human bronchial mucosa. J. Allergy Clin. Immunol.118(6), 1386–1388 (2006).
  • Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest.101(8), 1614–1622 (1998).
  • Hudson TJ. Skin barrier function and allergic risk. Nat. Genet.38(4), 399–400 (2006).
  • Callard RE, Harper JI. The skin barrier, atopic dermatitis and allergy: a role for langerhans cells? Trends Immunol.28(7), 294–298 (2007).
  • Rodriguez E, Baurecht H, Herberich E et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J. Allergy Clin. Immunol.123(6), 1361–1370 (2009).
  • Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J. Allergy Clin. Immunol.121(6), 1337–1343 (2008).
  • Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br. J. Dermatol.149(3), 582–589 (2003).
  • Rowe SM, Clancy JP. Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs23(3), 165–174 (2009).
  • Kerem E, Hirawat S, Armoni S et al. Effectiveness of ptc124 treatment of cystic fibrosis caused by nonsense mutations: a prospective Phase II trial. Lancet372(9640), 719–727 (2008).
  • Fiset PO, Leung DY, Hamid Q. Immunopathology of atopic dermatitis. J. Allergy Clin. Immunol.118(1), 287–290 (2006).
  • Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med.347(15), 1151–1160 (2002).
  • Howell MD, Kim BE, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol.120(1), 150–155 (2007).
  • Kootiratrakarn T, Fujimura T, Sano K et al. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. Eur. J. Immunol.35(11), 3277–3286 (2005).
  • Brown SJ, Mclean WH. Eczema genetics: current state of knowledge and future goals. J. Invest. Dermatol.129(3), 543–552 (2009).
  • Ainsworth C. Nonsense mutations: running the red light. Nature438(7069), 726–728 (2005).
  • Williams HC, Grindlay DJ. What’s new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema. Clin. Exp. Dermatol.35(1), 12–15 (2009).
  • Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br. J. Dermatol.158(4), 754–765 (2008).
  • Brown SJ, Irvine AD. Atopic eczema and the filaggrin story. Semin. Cutan. Med. Surg.27(2), 128–137 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.